H-Tyr-D-Ala-Gly-Phe-Met-NH2
Modify Date: 2024-01-08 14:43:04
H-Tyr-D-Ala-Gly-Phe-Met-NH2 structure
|
Common Name | H-Tyr-D-Ala-Gly-Phe-Met-NH2 | ||
|---|---|---|---|---|
| CAS Number | 61090-95-7 | Molecular Weight | 586.70300 | |
| Density | 1.286 g/cm3 | Boiling Point | 1057.4ºC at 760 mmHg | |
| Molecular Formula | C28H38N6O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 593.3ºC | |
Use of H-Tyr-D-Ala-Gly-Phe-Met-NH2[D-Ala2]-Met-Enkephalinamide, an opioid peptide, is a potent opioid agonist. [D-Ala2]-Met-Enkephalinamide decreases bile flow by a central mechanism. [D-Ala2]-Met-Enkephalinamide has analgesic properties[1][2]. |
| Name | 2-[[2-[[2-[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoylamino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide |
|---|---|
| Synonym | More Synonyms |
| Description | [D-Ala2]-Met-Enkephalinamide, an opioid peptide, is a potent opioid agonist. [D-Ala2]-Met-Enkephalinamide decreases bile flow by a central mechanism. [D-Ala2]-Met-Enkephalinamide has analgesic properties[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | [D-Ala2]-Met-Enkephalinamide decreases bile flow by a central mechanism in Sprague-Dawley rats[1]. Animal Model: Male Sprague-Dawley rats (250-320 g)[1] Dosage: 10, 50, 100, 150, and 200 mg/kg Administration: Intracerebroventrical injection Result: Decreased in bile flow that ranged from 12% to 41%. Decreased bicarbonate secretion into bile. |
| Density | 1.286 g/cm3 |
|---|---|
| Boiling Point | 1057.4ºC at 760 mmHg |
| Molecular Formula | C28H38N6O6S |
| Molecular Weight | 586.70300 |
| Flash Point | 593.3ºC |
| Exact Mass | 586.25700 |
| PSA | 231.04000 |
| LogP | 2.29780 |
| Index of Refraction | 1.601 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
|
~%
H-Tyr-D-Ala-Gly... CAS#:61090-95-7 |
| Literature: Audigier; Mazarguil; Gout; Cros European Journal of Medicinal Chemistry, 1980 , vol. 15, # 2 p. 173 - 177 |
![(2R)-2-[[(2S)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]amino]propanoic acid structure](https://www.chemsrc.com/caspic/259/71591-34-9.png)
| Precursor 9 | |
|---|---|
| DownStream 3 | |
CAS#:4510-08-1
CAS#:63-68-3
CAS#:63-91-2| DAME |
| [D-Ala2]Met-enkephalinamide |
| D-Enkephalin |
| Met-enkephalinamide,ala(2) |
| [D-Ala2-Met5]enkephalinamide |
| Methionine-enkephalinamide,ala(2) |
| Enkephalinamide-met,ala(2) |
| Tyr-D-Ala-Gly-Phe-Met-NH2 |
| Dalamid |
| Dalamide |
| 2-Ala-met-enkephalinamide |
| Enkephalinamide-met,alanine(2) |
| [D-Ala2]-methionine enkephalinamide |
| H-Tyr-D-Ala-Gly-Phe-Met-NH2 |
| Enkephalin, Amide-[D-Ala2, Met5] |